EUVIMEDEUVIMED entdecken
Crossref

Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer

S K Batabyal, R Majhi, P S Basu

Neoplasma · 2009

DOI: 10.4149/neo_2009_01_68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neoplasma, 2009. Verfasst von S K Batabyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Biochemistry Department, Nightingale Hospital, Kolkata, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedBiomarkers, TumorChromatography, High Pressure LiquidElectrophoresis, Polyacrylamide GelGlycosylationHumansLectinsMaleMiddle AgedPhytohemagglutininsProstate-Specific AntigenProstatic HyperplasiaProstatic Neoplasms

Substanzen

Biomarkers, TumorLectinsPhytohemagglutininsphytohemagglutinin L protein, Phaseolus vulgarisProstate-Specific Antigen

Autor:innen und Institutionen

  • Advanced Biochemistry Department, Nightingale Hospital, Kolkata, India.

Zitieren

APA

Batabyal, S. K., Majhi, R., & Basu, P. S. (2009). Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer. Neoplasma. https://doi.org/10.4149/neo_2009_01_68

Vancouver

Batabyal SK, Majhi R, Basu PS. Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer. Neoplasma. 2009. doi:10.4149/neo_2009_01_68

BibTeX
@article{Batabyal2009,
  author = {Batabyal, S K and Majhi, R and Basu, P S},
  title = {Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer},
  journal = {Neoplasma},
  year = {2009},
  doi = {10.4149/neo_2009_01_68}
}
Kostenlos starten →